| |
| |
|
| Insider
Information: |
Wg Biotech Aps |
| Relationship: |
Director |
| City: |
Rungsted Kyst |
| State: |
G7 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,559,233 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$55,166,719 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,559,233 |
|
|
| Total
Value |
$55,166,719 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Y-Mabs Therapeutics Inc |
YMAB |
Director |
2023-12-11 |
4,559,233 |
2019-12-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-12-11 |
4 |
B |
$6.85 |
$44,232 |
D/D |
6,455 |
4,559,233 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-12-11 |
4 |
B |
$7.01 |
$720,843 |
D/D |
102,863 |
4,552,778 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-12-08 |
4 |
B |
$6.99 |
$129,379 |
D/D |
18,503 |
4,449,915 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-12-07 |
4 |
B |
$6.50 |
$40,190 |
D/D |
6,183 |
4,431,412 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-11-29 |
4 |
B |
$5.97 |
$309,477 |
D/D |
51,837 |
4,425,229 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-11-28 |
4 |
B |
$5.81 |
$178,275 |
D/D |
30,671 |
4,373,392 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2023-11-27 |
4 |
B |
$5.49 |
$343,019 |
D/D |
62,516 |
4,342,721 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
– • – |
2023-05-15 |
4 |
B |
$9.65 |
$981,404 |
D/D |
101,740 |
4,280,205 |
2.39 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
– • – |
2021-06-10 |
4 |
S |
$36.15 |
$405,971 |
D/D |
(11,229) |
4,178,456 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See Remarks |
– • – |
2021-06-09 |
4 |
S |
$36.19 |
$4,223,116 |
D/D |
(116,700) |
4,189,694 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See Remarks |
– • – |
2021-06-08 |
4 |
S |
$35.28 |
$1,174,694 |
D/D |
(33,300) |
4,306,394 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2021-06-07 |
4 |
S |
$34.15 |
$2,472,583 |
D/D |
(72,400) |
4,339,694 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2021-06-04 |
4 |
S |
$34.03 |
$130,704 |
D/D |
(3,841) |
4,412,094 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2021-06-03 |
4 |
S |
$33.19 |
$1,017,670 |
D/D |
(30,666) |
4,415,935 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2021-06-01 |
4 |
S |
$35.57 |
$244,173 |
D/D |
(6,864) |
4,446,601 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2021-05-28 |
4 |
S |
$36.34 |
$908,475 |
D/D |
(25,000) |
4,453,465 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
10% Owner |
– – • |
2019-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
498,392 |
5,508,392 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
